Screener
Recursion Pharmaceuticals, Inc. RXRX Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other receivables | 14,393 | 24,649 |
| Prepaid data assets | 8,680 | 11,742 |
| Other current assets | 29,321 | 28,566 |
| Total current assets | 603,462 | 812,845 |
| Restricted cash, non-current | 5,752 | 6,033 |
| Property and equipment, net | 89,623 | 103,931 |
| Operating lease right-of-use assets | 40,271 | 45,339 |
| Financing lease right-of-use assets | 17,179 | 20,210 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s total current assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported total current assets of $603.46M in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s total current assets increased by 2.8% year-over-year, from $587.16M to $603.46M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s total current assets has grown at a 25.0% compound annual growth rate (CAGR), from $266.44M to $812.85M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Recursion Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude